IBD can also affect areas outside the gut, including joints, skin, and eyes – known as extra-intestinal manifestations.
What is the difference between IBS and IBD?
This is one of the most searched questions in gut health – and for good reason. The two conditions share overlapping symptoms but have fundamentally different causes, diagnoses, and treatments.
The key difference: IBS is a functional condition – the gut looks normal but behaves abnormally. IBD is a structural condition – the gut shows visible inflammation and damage.
Many people arrive at an IBD diagnosis after first being told they have IBS. If your symptoms have been dismissed or you're still searching for answers, you may require further investigations.
Is IBD a gut-brain disorder like IBS?
You may have heard the term 'gut-brain disorder’ or Disorder of Gut-Brain Interaction (DGBI) – which is used to describe conditions like IBS, functional dyspepsia, or rumination syndrome where the communication between the brain and the gut plays a central role in symptoms.
IBD is not a gut-brain disorder – instead, it’s an immune-mediated condition with a clear physical cause – inflammation – that requires medical treatment.
That said, IBD and gut-brain disorders are closely connected in important ways: many people with IBD also develop IBS-like symptoms even during remission, suggesting gut-brain dysregulation can co-exist.
Stress and anxiety don’t cause IBD, but they can trigger flares and worsen symptoms.
The gut microbiome – a key player in gut-brain communication – is often disrupted in people with IBD. And psychological support, mindfulness, and gut-directed therapies can meaningfully improve quality of life for people with IBD, even if they don't treat the inflammation itself.
So while IBD lives in a different category from IBS and other gut-brain conditions, the two worlds overlap more than most people realize.
How is IBD diagnosed?
If your healthcare provider suspects IBD, you'll likely have blood tests to check for inflammation and anemia, stool tests measuring inflammation markers like calprotectin, a colonoscopy to view the gut directly and take biopsies, and an MRI or CT scan to assess the extent of inflammation.
Reaching a definitive diagnosis can take time – in some cases, distinguishing between Chrons and UC (the 2 types of IBD) requires multiple investigations and even then the picture isn't always clear.²
If you're pre-diagnosis and waiting for these tests, it's okay to feel anxious. Write down your symptoms, note when they happen, and bring that information to your appointment – you are your own best advocate.
How do I treat IBD?
There is currently no cure for IBD, but effective treatments exist that can bring and maintain remission. The approach is highly individual – what works for one person may not work for another – and finding the right combination often takes time and close collaboration with your gastroenterologist.
Treatment typically involves some combination of medications including anti-inflammatories, immunosuppressants, and biologics, dietary support from a specialist dietitian, and mental health care to address the psychological weight of living with a chronic condition. For some people, surgery is necessary – and for those with Ulcerative Colitis, removing the colon and rectum eliminates the disease at its source.³
Dietary strategies can also play an important role in symptom management. As Binder explains, the Mediterranean diet is often the most practical starting point because it is less restrictive and appropriate in many IBD scenarios, while more restrictive diets may be considered in select cases.
Research also highlights that many IBD symptoms are not driven by active inflammation alone – making psychological support and stress management a meaningful part of comprehensive care, not just an afterthought.⁴ This is where the gut-brain connection becomes particularly relevant for people with IBD, even though IBD itself is not a gut-brain disorder.
Can I live a normal life with IBD?
IBD is a lifelong condition, but for most people it is manageable.
With an accurate diagnosis, the right treatment plan, and a care team that understands the condition, many people with IBD achieve long periods of remission and maintain a good quality of life.
The earlier it is identified and treated, the better the outcomes tend to be.
Frequently asked questions
Can IBD be silent with no symptoms?
Yes. Active inflammation can be present without obvious symptoms – sometimes called subclinical IBD. This is why regular monitoring matters even when you feel well, as damage can continue silently between flares.
Is IBD hereditary?
IBD is not directly inherited, but genetics play a role. Having a first-degree relative with IBD increases your risk. Most people with associated genetic variants never develop the condition, suggesting environment and the gut microbiome are also significant factors.
Can children get IBD?
Yes – IBD can develop at any age. It is increasingly diagnosed in children and teenagers, and is sometimes missed because symptoms overlap with other conditions. In children, IBD can also affect growth and development, making early diagnosis especially important.
What is an IBD flare?
A flare is a period of active inflammation when symptoms such as pain, diarrhea, and fatigue return or worsen. Between flares, many people experience remission – when symptoms ease significantly or disappear. The goal of treatment is to reduce the frequency and severity of flares.
Does IBD cause cancer?
IBD does not directly cause cancer, but long-standing IBD – particularly extensive Ulcerative Colitis – is associated with a moderately increased risk of colorectal cancer.⁵ The good news is that regular colonoscopies and keeping the disease well managed can meaningfully lower that risk.⁶
References
1. Solitano V, Bernstein CN, Dotan I, et al. Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response. Nat Rev Gastroenterol Hepatol. 2025;22:438–452. doi:10.1038/s41575-025-01063-x
2. Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives. World J Gastroenterol. 2015;21(1):21–46. doi:10.3748/wjg.v21.i1.21
3. Holubar SD, Lightner AL, Poylin V, et al. American Society of Colon and Rectal Surgeons clinical practice guidelines for the surgical management of ulcerative colitis. Dis Colon Rectum. 2021;64(7):783–804. doi:10.1097/DCR.0000000000002037
4. Bernstein CN. Treatment of IBD: where we are and where we are going. Am J Gastroenterol. 2015;110(1):114–126. doi:10.1038/ajg.2014.357
5. Olén O, Erichsen R, Sachs MC, et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet. 2020;395(10218):123-131.
6. Lutgens MWMD, van Oijen MGH, van der Heijden GJMG, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease. Gastroenterology. 2013;144(7):1484-1492.
.webp)
.jpeg)
.jpeg)
